Mike Stobbe | AP

Mike Stobbe is a Medical Writer for the Associated Press. He has written for various publications including Associated Press, Small Business Spotlight, Yahoo Life, Bloomberg Businessweek, Business Insider, CBS News, Daily Mail, HuffPost, KCNC-TV (Denver, CO), MSN (US), MSN Australia and is the author of the book Surgeon General's Warning: How Politics Crippled the Nation's Doctor. As a journalist, he can create a free Muck Rack account to customize his profile and upload a portfolio of his best work.

Biography:  https://muckrack.com/mike-stobbe

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • The article contradicts itself by stating that the committee recommended the vaccine for those in this age group who live in nursing homes or are deemed frail by their doctors.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Recommendations: Older Adults Strongly Encouraged to Get RSV Vaccine

New Recommendations: Older Adults Strongly Encouraged to Get RSV Vaccine

Broke On: Wednesday, 26 June 2024 The CDC strongly recommends the RSV vaccine for people aged 75 and above, following FDA licensing of single-dose vaccines from GSK, Pfizer, and Moderna. Older adults are at higher risk for severe RSV cases due to underlying health conditions. The benefits of vaccination outweigh potential risks, including Guillain-Barre syndrome concerns.